Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer

Abstract Background Breast cancer (BC) is the most commonly diagnosed cancer. Currently, mammography and breast ultrasonography are the main clinical screening methods for BC. Our study aimed to reveal the specific metabolic profiles of BC patients and explore the specific metabolic signatures in hu...

Full description

Bibliographic Details
Main Authors: Rui An, Haitao Yu, Yanzhong Wang, Jie Lu, Yuzhen Gao, Xinyou Xie, Jun Zhang
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Cancer & Metabolism
Subjects:
Online Access:https://doi.org/10.1186/s40170-022-00289-6
_version_ 1811340337748115456
author Rui An
Haitao Yu
Yanzhong Wang
Jie Lu
Yuzhen Gao
Xinyou Xie
Jun Zhang
author_facet Rui An
Haitao Yu
Yanzhong Wang
Jie Lu
Yuzhen Gao
Xinyou Xie
Jun Zhang
author_sort Rui An
collection DOAJ
description Abstract Background Breast cancer (BC) is the most commonly diagnosed cancer. Currently, mammography and breast ultrasonography are the main clinical screening methods for BC. Our study aimed to reveal the specific metabolic profiles of BC patients and explore the specific metabolic signatures in human plasma for BC diagnosis. Methods This study enrolled 216 participants, including BC patients, benign patients, and healthy controls (HC) and formed two cohorts, one training cohort and one testing cohort. Plasma samples were collected from each participant and subjected to perform nontargeted metabolomics and proteomics. The metabolic signatures for BC diagnosis were identified through machine learning. Results Metabolomics analysis revealed that BC patients showed a significant change of metabolic profiles compared to HC individuals. The alanine, aspartate and glutamate pathways, glutamine and glutamate metabolic pathways, and arginine biosynthesis pathways were the critical biological metabolic pathways in BC. Proteomics identified 29 upregulated and 2 downregulated proteins in BC. Our integrative analysis found that aspartate aminotransferase (GOT1), l-lactate dehydrogenase B chain (LDHB), glutathione synthetase (GSS), and glutathione peroxidase 3 (GPX3) were closely involved in these metabolic pathways. Support vector machine (SVM) demonstrated a predictive model with 47 metabolites, and this model achieved a high accuracy in BC prediction (AUC = 1). Besides, this panel of metabolites also showed a fairly high predictive power in the testing cohort between BC vs HC (AUC = 0.794), and benign vs HC (AUC = 0.879). Conclusions This study uncovered specific changes in the metabolic and proteomic profiling of breast cancer patients and identified a panel of 47 plasma metabolites, including sphingomyelins, glutamate, and cysteine could be potential diagnostic biomarkers for breast cancer.
first_indexed 2024-04-13T18:40:27Z
format Article
id doaj.art-1f5e1bbeee144a5f8e281de8405a3cea
institution Directory Open Access Journal
issn 2049-3002
language English
last_indexed 2024-04-13T18:40:27Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Cancer & Metabolism
spelling doaj.art-1f5e1bbeee144a5f8e281de8405a3cea2022-12-22T02:34:44ZengBMCCancer & Metabolism2049-30022022-08-0110111810.1186/s40170-022-00289-6Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancerRui An0Haitao Yu1Yanzhong Wang2Jie Lu3Yuzhen Gao4Xinyou Xie5Jun Zhang6Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineAbstract Background Breast cancer (BC) is the most commonly diagnosed cancer. Currently, mammography and breast ultrasonography are the main clinical screening methods for BC. Our study aimed to reveal the specific metabolic profiles of BC patients and explore the specific metabolic signatures in human plasma for BC diagnosis. Methods This study enrolled 216 participants, including BC patients, benign patients, and healthy controls (HC) and formed two cohorts, one training cohort and one testing cohort. Plasma samples were collected from each participant and subjected to perform nontargeted metabolomics and proteomics. The metabolic signatures for BC diagnosis were identified through machine learning. Results Metabolomics analysis revealed that BC patients showed a significant change of metabolic profiles compared to HC individuals. The alanine, aspartate and glutamate pathways, glutamine and glutamate metabolic pathways, and arginine biosynthesis pathways were the critical biological metabolic pathways in BC. Proteomics identified 29 upregulated and 2 downregulated proteins in BC. Our integrative analysis found that aspartate aminotransferase (GOT1), l-lactate dehydrogenase B chain (LDHB), glutathione synthetase (GSS), and glutathione peroxidase 3 (GPX3) were closely involved in these metabolic pathways. Support vector machine (SVM) demonstrated a predictive model with 47 metabolites, and this model achieved a high accuracy in BC prediction (AUC = 1). Besides, this panel of metabolites also showed a fairly high predictive power in the testing cohort between BC vs HC (AUC = 0.794), and benign vs HC (AUC = 0.879). Conclusions This study uncovered specific changes in the metabolic and proteomic profiling of breast cancer patients and identified a panel of 47 plasma metabolites, including sphingomyelins, glutamate, and cysteine could be potential diagnostic biomarkers for breast cancer.https://doi.org/10.1186/s40170-022-00289-6Breast neoplasmsPlasmaMetabolomicsProteomicsMachine learning
spellingShingle Rui An
Haitao Yu
Yanzhong Wang
Jie Lu
Yuzhen Gao
Xinyou Xie
Jun Zhang
Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
Cancer & Metabolism
Breast neoplasms
Plasma
Metabolomics
Proteomics
Machine learning
title Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
title_full Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
title_fullStr Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
title_full_unstemmed Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
title_short Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
title_sort integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
topic Breast neoplasms
Plasma
Metabolomics
Proteomics
Machine learning
url https://doi.org/10.1186/s40170-022-00289-6
work_keys_str_mv AT ruian integrativeanalysisofplasmametabolomicsandproteomicsrevealsthemetaboliclandscapeofbreastcancer
AT haitaoyu integrativeanalysisofplasmametabolomicsandproteomicsrevealsthemetaboliclandscapeofbreastcancer
AT yanzhongwang integrativeanalysisofplasmametabolomicsandproteomicsrevealsthemetaboliclandscapeofbreastcancer
AT jielu integrativeanalysisofplasmametabolomicsandproteomicsrevealsthemetaboliclandscapeofbreastcancer
AT yuzhengao integrativeanalysisofplasmametabolomicsandproteomicsrevealsthemetaboliclandscapeofbreastcancer
AT xinyouxie integrativeanalysisofplasmametabolomicsandproteomicsrevealsthemetaboliclandscapeofbreastcancer
AT junzhang integrativeanalysisofplasmametabolomicsandproteomicsrevealsthemetaboliclandscapeofbreastcancer